BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10687968)

  • 21. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transurethral approach to the distal ureter in nephroureterectomy: transurethral extraction vs. "pluck" technique with long-term follow-up.
    Ubrig B; Boenig M; Waldner M; Roth S
    Eur Urol; 2004 Dec; 46(6):741-7. PubMed ID: 15548441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
    Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
    J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ureteroscopy in the follow-up protocol for upper urinary tract urothelial tumors treated endoscopically].
    Amón Sesmero JH; Estébanez Zarranz J; Conde Redondo C; Robles Samaniego A; Del Valle González N; Martínez-Sagarra Oceja JM
    Arch Esp Urol; 2004 Apr; 57(3):303-10. PubMed ID: 15174509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma--China Medical University Hospital experience.
    Chen CH; Wu HC; Chen WC; Yeh CC; Chen CC; Chang CH
    Urology; 2005 Apr; 65(4):687-91. PubMed ID: 15833509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
    Sadek S; Soloway MS; Hook S; Civantos F
    J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
    Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
    Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes.
    Wolf JS; Dash A; Hollenbeck BK; Johnston WK; Madii R; Montgomery JS
    J Urol; 2005 Apr; 173(4):1102-7. PubMed ID: 15758710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
    Palou J; Piovesan LF; Huguet J; Salvador J; Vicente J; Villavicencio H
    J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter.
    Kenworthy P; Tanguay S; Dinney CP
    J Urol; 1996 Feb; 155(2):501-3. PubMed ID: 8558645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy.
    Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S
    World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Manabe D; Saika T; Ebara S; Uehara S; Nagai A; Fujita R; Irie S; Yamada D; Tsushima T; Nasu Y; Kumon H;
    Urology; 2007 Mar; 69(3):457-61. PubMed ID: 17382144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carcinoma recurrence rates after laparoscopic nephroureterectomy in patients undergoing transurethral incision of the ureteral orifice and open excision of bladder cuff].
    Zhang DX; Shen HL; Lü WC; Tian Y; Li J; Hao GY; Xiao J; DU LD
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2854-6. PubMed ID: 19080497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
    Clark PE; Streem SB; Geisinger MA
    J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.